144 related articles for article (PubMed ID: 36587984)
1. Macrophage Polarization Induced by Bacteria-Responsive Antibiotic-Loaded Nanozymes for Multidrug Resistance-Bacterial Infections Management.
Zhu X; Guo J; Yang Y; Liu J
Small; 2023 Mar; 19(11):e2204928. PubMed ID: 36587984
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin conjugated gold nanorods with pH induced surface charge transformable activities to combat drug resistant bacteria and their biofilms.
Yin M; Qiao Z; Yan D; Yang M; Yang L; Wan X; Chen H; Luo J; Xiao H
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112292. PubMed ID: 34474843
[TBL] [Abstract][Full Text] [Related]
3. Cationic chitosan@Ruthenium dioxide hybrid nanozymes for photothermal therapy enhancing ROS-mediated eradicating multidrug resistant bacterial infection.
Zhu X; Chen X; Jia Z; Huo D; Liu Y; Liu J
J Colloid Interface Sci; 2021 Dec; 603():615-632. PubMed ID: 34225068
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin Poly(β-amino ester) Conjugates Enhance Antibiofilm Activity and Slow the Development of Resistance.
Kasza K; Richards B; Jones S; Romero M; Robertson SN; Hardie KR; Gurnani P; Cámara M; Alexander C
ACS Appl Mater Interfaces; 2024 Feb; 16(5):5412-5425. PubMed ID: 38289032
[TBL] [Abstract][Full Text] [Related]
5. Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.
Ahmed MN; Porse A; Abdelsamad A; Sommer M; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307984
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.
Ahmed MN; Porse A; Sommer MOA; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760140
[TBL] [Abstract][Full Text] [Related]
7. Synergistic efficacy of meropenem, ciprofloxacin and colistin antibiotics against planktonic and biofilm forms of Myroides odoratimimus bacterial isolates.
Taşkın Kafa AH; Hasbek M
Indian J Med Microbiol; 2022; 40(3):399-403. PubMed ID: 35491280
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
9. Intelligent Jellyfish-type Janus Nanoreactor Targeting Synergistic Treatment of Bacterial Infections.
Huang Y; Liu D; Guo R; Wang B; Lu Y
ACS Appl Bio Mater; 2023 Jun; 6(6):2384-2393. PubMed ID: 37191675
[TBL] [Abstract][Full Text] [Related]
10. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants.
Silva E; Monteiro R; Grainha T; Alves D; Pereira MO; Sousa AM
Front Cell Infect Microbiol; 2020; 10():441. PubMed ID: 32974221
[TBL] [Abstract][Full Text] [Related]
11. Nano delivery systems to the rescue of ciprofloxacin against resistant bacteria "E. coli; P. aeruginosa; Saureus; and MRSA" and their infections.
Nwabuife JC; Omolo CA; Govender T
J Control Release; 2022 Sep; 349():338-353. PubMed ID: 35820538
[TBL] [Abstract][Full Text] [Related]
12. Dual acting acid-cleavable self-assembling prodrug from hyaluronic acid and ciprofloxacin: A potential system for simultaneously targeting bacterial infections and cancer.
Ibrahim UH; Devnarain N; Mohammed M; Omolo CA; Gafar MA; Salih M; Pant A; Shunmugam L; Mocktar C; Khan R; Oh JK; Govender T
Int J Biol Macromol; 2022 Dec; 222(Pt A):546-561. PubMed ID: 36150574
[TBL] [Abstract][Full Text] [Related]
13. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
Weldrick PJ; Hardman MJ; Paunov VN
ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
[TBL] [Abstract][Full Text] [Related]
15. Dual bioresponsive antibiotic and quorum sensing inhibitor combination nanoparticles for treatment of Pseudomonas aeruginosa biofilms in vitro and ex vivo.
Singh N; Romero M; Travanut A; Monteiro PF; Jordana-Lluch E; Hardie KR; Williams P; Alexander MR; Alexander C
Biomater Sci; 2019 Sep; 7(10):4099-4111. PubMed ID: 31355397
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
Tewes F; Bahamondez-Canas TF; Smyth HDC
AAPS PharmSciTech; 2019 May; 20(5):205. PubMed ID: 31144198
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic bionanocatalysts for combating peri-implant biofilm infections by specific heat-amplified chemodynamic therapy and innate immunomodulation.
Su Z; Kong L; Mei J; Li Q; Qian Z; Ma Y; Chen Y; Ju S; Wang J; Jia W; Zhu C; Fan W
Drug Resist Updat; 2023 Mar; 67():100917. PubMed ID: 36608472
[TBL] [Abstract][Full Text] [Related]
18. A ruthenium nanoframe/enzyme composite system as a self-activating cascade agent for the treatment of bacterial infections.
Liu Y; Huo D; Zhu X; Chen X; Lin A; Jia Z; Liu J
Nanoscale; 2021 Sep; 13(35):14900-14914. PubMed ID: 34533163
[TBL] [Abstract][Full Text] [Related]
19. Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer.
Li JJ; Hu Y; Hu B; Wang W; Xu H; Hu XY; Ding F; Li HB; Wang KR; Zhang X; Guo DS
Nat Commun; 2022 Oct; 13(1):6279. PubMed ID: 36270992
[TBL] [Abstract][Full Text] [Related]
20. Potential Risk of Spreading Resistance Genes within Extracellular-DNA-Dependent Biofilms of Streptococcus mutans in Response to Cell Envelope Stress Induced by Sub-MICs of Bacitracin.
Nagasawa R; Sato T; Nomura N; Nakamura T; Senpuku H
Appl Environ Microbiol; 2020 Aug; 86(16):. PubMed ID: 32532873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
